These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7977070)

  • 21. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
    Finance O; Manning A; Chatelain P
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W; Cho JG; Marchlinski FE
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
    Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
    Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H
    J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases.
    Romito G; Gemma N; Dondi F; Mazzoldi C; Fasoli S; Cipone M
    J Vet Cardiol; 2024 Jun; 53():20-35. PubMed ID: 38608438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
    Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
    Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
    Brachmann J; Schöls W; Beyer T; Montero M; Enders B; Kübler W
    Eur Heart J; 1993 Nov; 14 Suppl H():85-7. PubMed ID: 8293757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
    Naitoh N; Yamaura M; Tagawa M; Aizawa Y
    Jpn Heart J; 1998 Sep; 39(5):619-30. PubMed ID: 9925993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
    Huikuri HV; Yli-Mäyry S
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2103-7. PubMed ID: 1279607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J; Haines DE; Lerman BB; DiMarco JP
    Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential proarrhythmic effect of biventricular pacing: fact or myth?
    Shukla G; Chaudhry GM; Orlov M; Hoffmeister P; Haffajee C
    Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
    Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.
    Boriani G; Lubinski A; Capucci A; Niederle R; Kornacewicz-Jack Z; Wnuk-Wojnar AM; Borggrefe M; Brachmann J; Biffi M; Butrous GS;
    Eur Heart J; 2001 Dec; 22(23):2180-91. PubMed ID: 11913480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency-dependent electrophysiologic effects of amiodarone in humans.
    Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
    Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
    Tomlinson DR; Cherian P; Betts TR; Bashir Y
    Emerg Med J; 2008 Jan; 25(1):15-8. PubMed ID: 18156531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.